Publicerad: 2023-01-19 15:19 | Uppdaterad: 2023-01-19 15:29

Aktuella utlysningar, vecka 3, 2023

Grants Office tipsar om aktuella utlysningar

Svenska och nordiska anslag

Stipendier för forskningsvistelser - Stiftelsen för internationalisering av högre utbildning och forskning (STINT)

Genom ett samarbete med Japan Society for the Promotion of Science (JSPS) erbjuder STINT stipendier för forskningsvistelser i Japan. JSPS Summer Program 2023 är öppen för forskning inom humaniora, naturvetenskap och samhällsvetenskap. Program vänder sig till masterstudenter, doktorander och nyblivna doktorer för att under två sommarmånader få en möjlighet att bekanta sig med Japan och japansk forskning. Stipendiater väljs med utgångspunkt i deras möjliga bidrag till ett förbättrat forskningssamarbete mellan Japan och Sverige.

Ansökan skickas per e-post till

Closing date: January 26, 2023

More information

Forskningsanslag - Stiftelsen Patentmedelsfonden for Odontologisk Profylaxforskning

Stöder profylaxinriktad forskning mot resultat som kan tillämpas i klinisk odontologisk verksamhet för att främja oral hälsa och motverka oral ohälsa. Fonden ger även bidrag till profylaxinriktad forskning av mera grundforskningsbetonad karaktär, förutsatt att projekten är vetenskapligt högklassiga och ansökningarna är välmotiverade.

Projektbidrag tilldelas i första hand svenska, i andra hand nordiska och i tredje hand utomnordiska forskare. Prioritet ges till ansökningar med vetenskapligt nyhetsvärde och som avser fleråriga projekt med god ’vetenskaplig volym’. Sådana projekt kan tilldelas 3-årsanslag.

OBS! Ansökan med bilagor insändes via e-mail till och skall ha inkommit senast den 1 februari ansökningsåret. Därutöver skall ett exemplar av ansökningsblanketten – med underskrifter – insändas i original via brev och skall ha inkommit till PMF:s sekreterare senast den 15 februari ansökningsåret.

Closing date: February 1, 2023

More information

Grant for clinical study within therapy research – The Swedish Research Council

 Supports clinical therapy studies that are justified by the needs of health and medical care and are expected to lead to patient and societal benefit within a relatively short period of time. Therapy studies refers to both intervention and observation studies. Areas such as prevention, diagnostics, follow-up, implementation, care and rehabilitation are also included. The grant aims to enable a constellation of researchers within regions and academia to work towards a common research goal.

Closing date: February 21, 2023

More information

Distinguished professor grant within medicine and health – Swedish Research Council

 Aims to create conditions for the most prominent researchers to conduct long-term, ground-breaking research with great potential for achieving scientific breakthroughs. The grant shall also enable the establishment and build-up of a major research environment of the highest quality around a leading researcher supporting the collaborations. Eligible applicants are individual researcher who completed a doctoral degree more than 12 years ago. No other researchers may be invited to join the application. Grant is given for 8 years and amounts to 4 000 000 SEK per year

Closing date: February 21, 2023

More information

Forskningsstipendier - Svenska Kardiologföreningen och AstraZeneca

Utlysningen gäller två stipendier för forskning inom akuta koronara syndrom och hjärtsvikt. 

1 Forskningsstipendium inom akuta koronara syndrom utlyses för att stimulera klinisk forskning inom området akut omhändertagande och sekundärpreventiv långtidsuppföljning av patienter med akuta koronara syndrom.

2) Forskningsstipendium inom hjärtsvikt utlyses för att stimulera klinisk forskning inom området Hjärtsvikt.

Stipendierna vänder sig i första hand till forskare som ännu inte uppnått docentur, t.ex. doktorander och post docs inom kardiologi/kardiovaskulär medicinSökande ska vara medlem i Svenska Kardiologföreningen.

Closing date: February 28, 2023.

More information

DDLS and WASP joint call 2022

In the light of last year’s successful cooperation, WASP and the SciLifeLab and Wallenberg National Program on Data-Driven Life Science (DDLS), are now announcing their second joint project call. The aim of the collaborative projects is to bridge the gap between data science and life science and create unique resources of competence and technical abilities, to solve ground-breaking research questions.

DDLS and WASP have a strong ambition to form solid collaborations by bridging the gap between their scientific disciplines respectively. The Knut and Alice Wallenberg foundation has earmarked funding for such collaborations in their donations to both these programs. To amplify their collaboration, DDLS and WASP announce a second call for proposals for joint research projects. Visit the call site here.

Closing date: 31 March, 2023

More information 


WASP and DDLS networking event January 2023

Friday 27/1 2023, 11:00–14:00

The second WASP-DDLS joint call for research project: Information and networking event 

This networking event welcomes everyone that wants to learn more about the second WASP-DDLS joint call for research projects. The event will start with an open Zoom meeting that will give an introduction to the new call and also highlight lessons learned from previous approved projects. The digital introduction will be followed by on-site network meetings at different university sites.

Deadline for registration January 18th

More information

Europeiska anslag

Horizon Europe Framework Programme – Global Challenges and European Industrial Competitiveness

Mission: Cancer (2023/24)

The goal of the Mission on Cancer is to improve the lives of more than 3 million people by 2030, through prevention, cure and for those affected by cancer including their families, to live longer and better. 

Current open calls:

Pragmatic clinical trials on minimally invasive diagnostics


Research and Innovation Actions

Addressing poorly-understood tumour-host interactions to enhance immune system-centred treatment and care interventions in childhood, adolescent, adult and elderly cancer patients.


Research and Innovation Actions

Enhance primary cancer prevention through sustainable behavioural change


Research and Innovation Actions

Establish best practices and tools to improve the quality of life for childhood cancer patients, survivors and their families in European regions


Innovation Actions

Closing date: 12 April 2023


Tackling diseases and reducing disease burden (2023/24)

This destination will focus on major societal challenges linked to the Commission’s political priorities such as the fight against cancer and other non-communicable diseases, better diagnosis and treatment of rare diseases, preparedness and response to and surveillance of health threats and epidemics, reduction of the number of antimicrobial-resistant infections, improving vaccination rates, demographic change, mental health and digital empowerment in health literacy.

Current open calls:

Interventions in city environments to reduce risk of non-communicable disease (Global Alliance for Chronic Diseases - GACD)


Research and Innovation Actions

Pandemic preparedness and response: Understanding vaccine induced-immunity


Research and Innovation Actions

Pandemic preparedness and response: Broad spectrum anti-viral therapeutics for infectious diseases with epidemic potential


Research and Innovation Actions

Pandemic preparedness and response: Immunogenicity of viral proteins of viruses with epidemic and pandemic potential


Research and Innovation Actions

Relationship between infections and non-communicable diseases


Research and Innovation Actions

Closing date: 13 April 2023


Unlocking the full potential of new tools, technologies and digital solutions for a healthy society (2023/24)

This destination has a strong focus on the personalisation of health technologies and will address the following issues:
-Developing computational systems for point-of-care applications, developing and validating computational models of physiological systems and integrating health data from different sources, for better patient management and improved clinical outcomes;
-Fostering translational biomedical research and advancing regenerative medicine approaches into clinical settings and manufacturing;
-Preparing for potential cross-border health threats through the development of innovative in-vitro-diagnostics;
-Supporting the establishment of the European Health Data Space by designing a data quality label.

Current open calls:

Clinical trials of combined Advanced Therapy Medicinal Products (ATMPs)


Research and Innovation Actions

Better integration and use of health-related real-world and research data, including genomics, for improved clinical outcomes


Research and Innovation Actions

Integrated, multi-scale computational models of patient patho-physiology (‘virtual twins’) for personalised disease management


Research and Innovation Actions

Harnessing the potential of real-time data analysis and secure Point-of-Care computing for the benefit of person-centred health and care delivery


Innovation Actions

Pandemic preparedness and response: In vitro diagnostic devices to tackle cross-border health threats


Innovation Actions

Closing date: 13 April 2023


Maintaining an innovative, sustainable and globally competitive health industry (2023/24)

This destination will focus on research and innovation activities that aim at:

-Facilitating the production of pharmaceuticals in compliance with the objectives of the European Green Deal.
-Developing methodologies, guidelines and standards, assessment studies, and structuring activities adapted to digital solutions and interventions for GDPR compliant translation into health care practice, including inter-operability, cyber-security and data confidentiality.
-Supporting public authorities with better methodologies and interdisciplinary approaches to assess and value new health technologies and interventions.

Current open calls:

Development and harmonisation of methodologies for assessing digital health technologies in Europe


Research and Innovation Actions

Expanding the European Electronic Health Record exchange Format to improve interoperability within the European Health Data Space


Research and Innovation Actions

Modelling and simulation to address regulatory needs in the development of orphan and paediatric medicines


Research and Innovation Actions

Closing date: 13 April 2023


Living and working in a health-promoting environment (2023/24)

This destination focuses on pollution, disrupting chemicals, environmental degradation, climate and other environmental exposures in living and working environments. The results will support the EU’s environment and health policies and overarching policy frameworks such as the European Green Deal, the Chemical Strategy for Sustainability, the EU Adaptation Strategy, the EU Biodiversity Strategy 2030, the 8th Environment Action Programme, the EU Strategic Framework on Health and Safety at Work as well as the WHO European Environment and Health Process (EHP).

Current open calls:

Health impacts of endocrine-disrupting chemicals: bridging science-policy gaps by addressing persistent scientific uncertainties


Research and Innovation Actions

Evidence-based interventions for promotion of mental and physical health in changing working environments (post-pandemic workplaces)


Research and Innovation Actions

Planetary health: understanding the links between environmental degradation and health impacts


Research and Innovation Actions

Closing date: 13 April 2023


Ensuring access to innovative, sustainable and high-quality health care (2023/24)

Under this destination, research and innovation aims at supporting health care systems in their transformation to ensure fair access to sustainable health care services of high quality for all citizens. Funded activities should support the development of innovative, feasible, implementable, financially sound and scalable solutions in the various dimensions of health care systems (e.g. governance, financing, human and physical resources, health service provision, and patient empowerment). 

Current open calls:

Maintaining access to regular health and care services in case of cross-border emergencies


Research and Innovation Actions

Resilience and mental wellbeing of the health and care workforce


Research and Innovation Actions

Environmentally sustainable and climate neutral health and care systems


Research and Innovation Actions

Closing date: 13 April 2023


Staying healthy in a rapidly changing society (2023/24)

Research and innovation supported under this destination will provide new tools, digitally enabled solutions and evidence-based health and care services to prevent and delay progression of age-related diseases. Research and innovation will also provide tailor made strategies and solutions to support children and adolescents adopting and maintaining person-centred healthy lifestyles. 

Current open calls:

The Silver Deal - Person-centred health and care in European regions


Research and Innovation Actions

Closing date: 13 April 2023


ERC Advanced Grants 2023 call

On December 8th, 2022, the European Research Council (ERC) opened its call for applications for ERC Advanced Grants 2023. These support ground-breaking, high-risk high-gain projects carried out by an established, leading principal investigator in any field of research. Applicants are expected to be active researchers who have a track record of significant research achievements in the last 10 years and should be exceptional leaders in terms of originality and significance of their research contributions.

Each grant is worth up to €2.5m over five years. An additional €1m may be requested.

Submission deadline: 23/05/2023

Please contact Grants Office if you are interested in applying with KI as host institution (

• ERC Advanced Grants official web page -- Who can apply and with what type of project?

• ERC Work Programme 2023

• Information for Applicants_ERC_AdG_2023

• KI ERC web pages -- Applying for an ERC grant with KI as Host Institution

Amerikanska anslag

Federal Funding agencies

Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional): NIH

The NIMH invites applications for Research Project Grants (R21) that advance innovative research to optimize HIV prevention and care. Applications may include novel basic or applied behavioral and social science to better understand a step or steps in the HIV prevention or care continuum, and/or preliminary research to identify and advance innovative intervention approaches.

This FOA, R21 PAR-23-061 uses the R21 grant mechanism to conduct exploratory, novel studies that break new ground, extend previous discoveries in new directions or result in novel techniques or models. Applications with preliminary data and/or those including longitudinal analysis, advanced modeling, or large-scale clinical trials or implementation science approaches should consider using the R01 mechanism (R01 PAR-23-062), Applicants proposing the initial development and pilot testing of a clinical trial or formative implementation research should consider using the R34 mechanism (PAR-23-060).

Deadline: May 9, 2023. Applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PAR-23-061

Further information 

Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional): NIH

The purpose of this Funding Opportunity Announcement (FOA) is to invite exploratory/developmental research grant applications (R21) for innovative informatics methods and algorithms to improve the acquisition, analysis, visualization, or interpretation of data across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Program, the emphasis of this FOA is on supporting the development of novel informatics capabilities that involve a high degree of innovation that have the potential to accelerate or enhance research. To be successful, there must be a clear rationale for how the proposed informatics method or algorithm is novel and how it will benefit the cancer research field.

Deadline: June 13, 2023. Applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): RFA-CA-23-014

Further information 

Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional): NIH

This FOA encourages applications at the intersection of HIV and aging by addressing two overarching objectives: 1) to improve understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment; and 2) to improve approaches for testing, prevention, and treatment of HIV infection, and management of HIV-related comorbidities, co-infections, and complications in different populations and cultural settings by applying our current understanding of aging science. Studies that move the science of HIV and aging into new directions with little or no preliminary data are appropriate for this activity code.

Deadline: Standard AIDS dates apply. Applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PAR-21-069

Further information 


New Academic Investigators Program, Target ALS, US

Target ALS is focused on identifying and supporting ideas of the next generation of ALS research leaders through the New Academic Investigators program. Target ALS is especially interested in proposals that apply novel methods to tackle fundamental questions of biology, drug development, and biomarker identification for ALS or ALS/FTD. Target ALS is looking to support projects that propose:

  • Identification, validation, and development of new targets for therapeutics; or
  • Development of biomarkers, tools, and technologies to facilitate human proof-of-biology studies.

Eligibility: Individual investigators (M.D.s or Ph.D.s) who have established their independent lab in an academic institution within the last five years (on or after March 17, 2018).

Budget: $130,000 per year for three years, for a total possible grant of $390,000. The initial grant will be for a two-year period. A lab will be eligible to compete for a third year of funding based on a competitive review of updated project goals as well as compelling progress at the end of second year of funding. Indirect costs up to 15% covered.

Deadline: LOI – 17th March, 2023. Full application (by invitation) – June, 2023.

More information 

Childhood Arthritis and Rheumatology Research Alliance CARRA, US

Career Development Award. This mentored award supports an early career investigator (Fellow, Assistant Professor) who demonstrates a clear track record and commitment to developing an independent research career in pediatric rheumatology. Eligibility: The project PI must be a CARRA member in good standing. All grants must be submitted by or include a pediatric rheumatologist named as a Co-Investigator. Budget: This award provides a three-year grant of $375,000. Indirect costs are not permitted.

Health Equity Research Grant. CARRA was founded on principles of inclusivity and collaboration, and we continue to promote our mission and vision with these thoughts as our core values. This CARRA-Arthritis Foundation grant mechanism funds research that addresses topics along the health equity research spectrum. This includes but is but not limited to: Methods to improve the identification and measurement of root causes of health inequities in pediatric rheumatology; Strategies to increase the representation of minoritized groups in pediatric rheumatology research; Translational research that identifies how social determinants of health are embodied to affect disease onset, severity, and outcomes; and/or Interventions designed to reduce or eliminate health disparities and/or address health inequities in pediatric rheumatology. Eligibility: The project PI must be a CARRA member in good standing. Budget: The grants provide $150,000 over two years. Indirect costs are not covered.

Large Grants. This grant supports the development and publication of a clinical or translational project that will immediately impact research projects conducted by CARRA or result in a more significant collaborative grant that furthers CARRA’s mission. New or early investigators are encouraged to apply. A successful application may be for: an all-inclusive clinical or translational research project, or a pilot research project, that if successful, could lead to extramural funding. Preference will be given to submissions that are collaborative and leverage current CARRA network resources or will further develop the CARRA network. Eligibility: The project PI must be a CARRA member in good standing. Budget: The grants provide $100,000 over two years. Indirect costs are not covered.

Deadline: 15th March, 2023.

More information 

Young Investigator Grant, Myelodysplastic Syndromes Foundation, US

The purpose of this Young Investigator Grant is to provide an investigator, that is early in their career, the opportunity to initiate, continue or complete a project that focuses on either basic or clinical management into the causation, epidemiology, molecular biology, cytogenetics, morphology, prognosis and treatment of the Myelodysplastic Syndromes or related myeloid neoplasms.

Eligibility: An investigator, US or International, that is early in their career as defined - Principal Investigator (PD/PI) who has completed their terminal research degree or end of post-graduate clinical training, whichever date is later, within the past 10 years and who has NOT previously competed successfully as PD/PI for a substantial independent research award (i.e., NIH, Leukemia Society grant or equivalent). An additional year may be granted to those who chose to serve as chief residents or for military service.

Budget: The Award of $50,000 per year will be provided for two years (grant total of $100,000). Up to 10% indirect costs are covered by this award.

Deadline: 3rd March, 2023

More information 

Bridge to Independence Award Program, Simons Foundation Autism Research Initiative, US

The Bridge to Independence (BTI) Award program engages talented early-career scientists in autism research by facilitating their transition to research independence and providing grant funding at the start of their professorships. The annual RFA is aimed at Ph.D. and M.D.-holding scientists who are currently in training positions but intend to seek tenure-track research faculty positions during the upcoming academic cycle. While we encourage applications from scientists who are working on autism-related projects, we would like to stress that this award is also open to researchers who are not currently working on autism but who are interested in starting research projects in this area and who have expertise that could be brought to bear on this complex condition.

Eligibility: Request for applications (RFA) open each year and are aimed at scientists with a Ph.D. and/or M.D. who are currently in training positions but intend to seek tenure-track research faculty positions during the upcoming academic job cycle.

Budget: Fellows will receive up to two years of postdoctoral fellowship support with an annual salary of $70,000, fringe benefits, an annual resource and professional development allowance of $10,000, and indirect costs (limited to 20 percent of modified total direct costs) followed by a commitment of $600,000 over three years, including indirect costs (limited to 20 percent of modified total direct costs) activated upon assumption of a tenure-track research professorship.

Deadline: 16th February, 2023.

More information